












"an impressive set with quality from the top
silk down to the most junior barristers."
Chambers & Partners (Information Technology) 2013
'Top drawer IP set.'
Legal 500 2010
'A veritable powerhouse of IP expertise'
Chambers and Partners 2011
"There are great people there at all levels and the clerks are very accommodating."
Chambers & Partners (Intellectual property) 2014
"8 New Square brims with barristers experienced in fighting fiendishly complex, high-value IT and telecoms disputes."
Chambers & Partners 2014
"8 New Square is undoubtedly one of the leading sets for trade mark and copyright cases within the media and entertainment sphere, so much so that stablemates here frequently find themselves pitted against each other in major cases."
Chambers & Partners (Media & Entertainment) 2014
"8 New Square brims with barristers experienced in fighting fiendishly complex, high-value IT and telecoms disputes."
Chambers & Partners (Information Technology) 2014
'An incredibly good set for IP matters'.
Legal 500 2010
'Practical and helpful clerks" provide a "smooth and personable service.'
Chambers and Partners 2011
'excellence on IT matters'
Legal 500 (Information Technology) 2010
'A number of great IT and telecoms barristers.'
Legal 500 2010
"Fantastic roster of talent" and recommended for being "very modern, forward-thinking and providing sound commercial advice" as well as offering instructing solicitors "a very broad skill set in the soft IP space."
Chambers & Partners 2017
The clerks are described as "helpful," "generous" and "very good at knowing what you want."
Chambers & Partners (Intellectual Property) 2013
Actavis v Novartis [2010] EWCA Civ 82
Case Summary | Judgment | 7 February 2010
This was the appeal in the action to revoke Novartis’ patent for its LESCOL® sustained release fluvastatin product. Richard Meade and Mark Chacksfield were instructed by Novartis. The appeal focused in detail on the requirements set down by the House of Lords in the recent Angiotech decision on the question of assessing inventive step.